Author Details

Artamonova, E V

Issue Section Title File
Vol 3, No 4 (2001) Articles Ftorafur - pervyy peroral'nyy ftorpirimidin v terapii metastaticheskogo kolorektal'nogo raka PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 3, No 4 (2001) Articles Novye immunologicheskie markery (CD71 , LU-BCRU-G7), vzaimosvyazannye s prognozom raka molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 10, No 1 (2008) Articles Ad\"yuvantnoe lechenie raka tolstoy kishki PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 11, No 3 (2009) Articles Mesto tsetuksimaba v terapii metastaticheskogo raka tolstoy kishki PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 11, No 4 (2009) Articles Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 12, No 1 (2010) Articles Original'naya kombinatsiyaFtorafur® + vinorelbinv lechenii raka molochnoy zhelezy:pervye rezul'taty PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 12, No 2 (2010) Articles Mesto Taksotera v terapiimetastaticheskogo raka molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 12, No 3 (2010) Articles Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 13, No 2 (2011) Articles Rezhimy na osnove Taksotera®v terapii HER-2-pozitivnogo rakamolochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 15, No 2 (2013) Articles New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 15, No 3 (2013) Articles Prolongirovannaya blokada angiogeneza pri metastaticheskom kolorektal'nom rake (novye dannye) PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 16, No 1 (2014) Articles New aspects of the first-line chemotherapy in colorectal cancer PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 16, No 2 (2014) Articles Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 17, No 2 (2015) Articles Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 18, No 1 (2016) Articles The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options PDF
(Rus)
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 19, No 1 (2017) Articles Albumin-bound paclitaxel in the treatment of metastatic breast cancer PDF
(Rus)
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 19, No 3 (2017) Articles Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving PDF
(Rus)
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 13, No 3 (2011) Articles Kapetsitabin v terapiiantratsiklin- i taksanrezistentnogoraka molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 13, No 3 (2011) Articles Novye vozmozhnostiv lechenii raka pryamoy kishki PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 14, No 1 (2012) Articles Dotsetaksel v ad\"yuvantnoy terapiirannego raka molochnoy zhelezy bezporazheniya limfaticheskikh uzlov (N0) PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 14, No 3 (2012) Articles Podderzhivayushchaya terapiya pri metastaticheskom kolorektal'nom rake: odin iz variantov vybora ili novyy standart lecheniya? PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 14, No 4 (2012) Articles Ingibitory tirozinkinazy EGFR v terapii 1-y linii nemelkokletochnogo raka legkogo: perekhod ot empiricheskogo podkhoda k personalizatsii lecheniya PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 20, No 3 (2018) Articles Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients PDF
(Rus)

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).